Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 4, 2016, Pages

  Ford, Alexander C ^a   Gurusamy, Kurinchi Selvan ^b   Delaney, Brendan ^c   Forman, David ^d   Moayyedi, Paul ^e  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIULCER AGENT; BISMUTH SALT; CIMETIDINE; CLARITHROMYCIN; ESOMEPRAZOLE; FAMOTIDINE; LANSOPRAZOLE; MACROLIDE; NITROIMIDAZOLE; NIZATIDINE; OMEPRAZOLE; PANTOPRAZOLE; RABEPRAZOLE; RANITIDINE; RANITIDINE BISMUTH CITRATE; SUCRALFATE; TETRACYCLINE; ANTIINFECTIVE AGENT;

BACTERIAL CLEARANCE; DIARRHEA; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DUODENUM ULCER; EPIGASTRIC PAIN; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; NAUSEA; PEPTIC ULCER; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT PEPTIC ULCER; REVIEW; RISK ASSESSMENT; STOMACH ULCER; STOMATITIS; SYSTEMATIC REVIEW; TREATMENT DURATION; ULCER HEALING; VOMITING; ADULT; COMBINATION DRUG THERAPY; DUODENAL ULCER; HELICOBACTER INFECTIONS; META ANALYSIS; MICROBIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; DRUG THERAPY, COMBINATION; DUODENAL ULCER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STOMACH ULCER;

EID: 84963800319     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003840.pub5     Document Type: Review

References (110)

1. Arkkila PET, Seppala K, Kosunen TU, Sipponen P, Makinen J, Rautelin H, et al. Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers. European Journal of Gastroenterology and Hepatology 2005;17:93-101.
2. Asaka M, Sugiyama T, Kato M, Satoh K, Kuwayama H, Fukuda Y, et al. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Helicobacter 2001;6(3):254-61.
3. Avsar E, Kalayci C, Tözün N, Lawrence R, Kiziltas S, Gültekin O, et al. Refractory duodenal ulcer healing and relapse: comparison of omeprazole with Helicobacter pylori eradication. European Journal of Gastroenterology and Hepatology 1996;8(5):449-52.
4. Axon AT, O'Moráin CA, Bardhan KD, Crowe JP, Beattie AD, Thompson RP, et al. Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection. BMJ 1997;314(7080):565-8.
5. Bardhan KD, Dallaire C, Eisold H, Duggan AE. Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer. Gut 1997;41(2):181-6.
6. Bayerdorffer E, Mannes GA, Sommer A, Hochter W, Weingart J, Hatz R, et al. High dose omeprazole treatment combined with amoxicillin eradicates Helicobacter pylori. European Journal of Gastroenterology and Hepatology 1992;4:697-702.
7. Bayerdorffer E, Mannes GA, Sommer A, Höchter W, Weingart J, Hatz R, et al. Long-term follow-up after eradication of Helicobacter pylori with a combination of omeprazole and amoxycillin. Scandinavian Journal of Gastroenterology 1993;28 Suppl 196:19-25.
8. Miehlke S, Bayerdörffer E, Lehn N, Mannes GA, Sommer A, Höchter W, et al. Two-year follow-up of duodenal ulcer patients treated with omeprazole and amoxicillin. Digestion 1995;56(3):187-93.
9. Bayerdorffer E, Miehlke S, Mannes GA, et al. Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology 1995;108:1412-17.
10. Bayerdorffer E, Miehlke S, Lehn N, Mannes GA, Höchter W, Weingart J, et al. Cure of gastric ulcer disease after cure of Helicobacter pylori infection-German Gastric Ulcer Study. European Journal of Gastroenterology and Hepatology 1996;8(4):343-9.
11. Befrits R, Sjostedt S, Tour R, Leijonmarck C-E, Hedenborg L, Backman M. Long-term effects of eradication of Helicobacter pylori on relapse and histology in gastric ulcer patients: a two-year follow-up study. Scandinavian Journal of Gastroenterology 2004;39:1066-72.
12. Bianchi Porro G, Parente F, Lazzaroni M. Short and long term outcome of Helicobacter pylori-positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or sucralphate alone. Gut 1993;34:466-9.
13. Bianchi Porro G, Lazzaroni M, Bargiggia S, Maconi G, Trespi E, Perego M, et al. Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence. American Journal of Gastroenterology 1996;91(4):695-700.
14. Carpintero P, Blanco M, Pajares JM. Ranitidine versus colloidal bismuth subcitrate in combination with amoxicillin and metronidazole for eradicating Helicobacter pylori in patients with duodenal ulcer. Clinical Infectious Diseases 1997;25:1032-7.
15. Chen TS, Tsay SH, Chang FY, Lee SD. Triple therapy for the eradication of Helicobacter pylori and reduction of duodenal ulcer relapse: comparison of 1 week and 2 week regimens and recrudescence rates over 12 months. Journal of Gastroenterology and Hepatology 1995;10:300-5.
16. Feng L-Y, Yao X-X, Jiang S-L. Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomised double-blind clinical trial. World Journal of Gastroenterology 2005;11(7):1083-6.
17. Figueroa G, Acuna R, Troncoso M, Portell DP, Toledo MS, Albornoz V, et al. Low H. pylori reinfection rate after triple therapy in Chilean duodenal ulcer patients. American Journal of Gastroenterology 1996;91(7):1395-9.
18. Fukuda Y, Yamamoto I, Okui M, Tonokatsu Y, Tamura K, Shimoyama T. Combination therapy with mucosal protective agent for the eradication of Helicobacter pylori. European Journal of Gastroenterology and Hepatology 1995;7 (Suppl 1):S45-S47.
19. Fukuda Y, Yamamoto I, Okui M, Tonokatsu Y, Shimoyama T. Combination therapies with a proton pump inhibitor for Helicobacter pylori-infected gastric ulcer patients. Journal of Clinical Gastroenterology 1995;20 (Suppl 2):S132-5.
20. Furuta T, Futami H, Arai H, Hanai H, Kaneko E. Effects of lansoprazole with or without amoxicillin on ulcer healing: relation to eradication of Helicobacter pylori. Journal of Clinical Gastroenterology 1995;20 (Suppl 2):S107-11.
21. Graham DY, Lew GM, Evans DG, Evans DJJ, Klein PD. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. Annals of Internal Medicine 1991;115(4):266-9.
22. Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ Jr, Saeed ZA, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Annals of Internal Medicine 1992;116(9):705-8.
23. Graham DY, Breiter JR, Ciociola AA, Sykes DL, McSorley DJ. An alternative non-macrolide, non-imidazole treatment regimen for curing Helicobacter pylori and duodenal ulcers: ranitidine bismuth citrate plus amoxicillin. The RBC H. pylori Study Group. Helicobacter 1998;3(2):125-31.
24. Harford W, Lanza F, Arora A, Graham D, Haber M, Weissfeld A, et al. Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection. Helicobacter 1996;1(4):243-50.
25. Hentschel E, Brandstätter G, Dragosics B, Hirschl AM, Nemec H, Schütze K, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. New England Journal of Medicine 1993;328(5):308-12.
26. Higuchi K, Fujiwara Y, Tominaga K, Watanabe T, Shiba M, Nakamura S, et al. Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori? A randomized, controlled prospective study. Alimentary Pharmacology and Therapeutics 2003;17(1):111-7.
27. Hosking SW, Ling TK, Yung MY, Cheng A, Chung SC, Leung JW, et al. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. BMJ 1992;305(6852):502-4.
28. Sung JJ, Chung SC, Ling TKW, Yung MY, Cheng AF, Hosking SW, et al. One-year follow-up of duodenal ulcers after 1-week triple therapy for Helicobacter pylori. American Journal of Gastroenterology 1994;89(2):199-202.
29. Kato M, Asaka M, Kudo M, Sukegawa M, Katagiri M, Koshiyama T, et al. Effects of lansoprazole plus amoxycillin on the cure of Helicobacter pylori infection in Japanese peptic ulcer patients. Alimentary Pharmacology and Therapeutics 1996;10(5):821-7.
30. Katoh M, Asaka M, Kudoh M, Kagaya H, Katagiri M, Takeda H. Clinical efficacy of lansoprazole in eradication of Helicobacter pylori. Journal of Clinical Gastroenterology 1995;20 (Suppl 2):S112-S114.
31. Kepekci Y, Kadayifci A. Does the eradication of Helicobacter pylori cure duodenal ulcer disease in communities with a high prevalence rate? Comparison with long-term acid suppression. International Journal of Clinical Practice 1999;53(7):505-8.
32. Kim JS, Kim SG, Choi IJ, Park MJ, Kim BG, Jung HC, et al. Effect of Helicobacter pylori eradication on duodenal ulcer scar in patients with no clinical history of duodenal ulcer. Alimentary Pharmacology and Therapeutics 2002;16(2):275-80.
33. Lam SK, Ching CK, Lai KC, Wong BC, Lai CL, Chan CK, et al. Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomised double blind placebo controlled study. Gut 1997;41(1):43-8.
34. Lazzaroni M, Perego M, Bargiggia S, Maconi G, Fiocca R, Solcia E, et al. Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: a two-year, double-blind, placebo controlled study. Italian Journal of Gastroenterology and Hepatology 1997;29(3):220-7.
35. Lin JT, Wang JT, Wu MS, Lee WY, Yang JC, Wang TH. Prospective, randomized study of H2-blocker and triple therapy for duodenal ulcer treatment and the eradication of Helicobacter pylori. Journal of the Formosan Medical Association 1994;93(5):368-73.
36. Logan RP, Bardhan KD, Celestin LR, Theodossi A, Palmer KR, Reed PI, et al. Eradication of Helicobacter pylori and prevention of recurrence of duodenal ulcer: a randomized, double-blind, multi-centre trial of omeprazole with or without clarithromycin. Alimentary Pharmacology and Therapeutics 1995;9(4):417-23.
37. Malfertheiner P, Bayerdörffer E, Diete U, Gil J, Lind T, Misiuna P, et al. The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Alimentary Pharmacology and Therapeutics 1999;13(6):703-12.
38. Mantzaris GJ, Hatzis A, Tamvakologos G, Petraki K, Spiliades C, Triadaphyllou G. Prospective, randomized, investigator-blind trial of Helicobacter pylori infection treatment in patients with refractory duodenal ulcers. Healing and long-term relapse rates. Digestive Diseases and Sciences 1993;38(6):1132-6.
39. Meining A, Höchter W, Weingart J, Sommer A, Klann H, Simon T, et al. Double-blind trial of omeprazole and amoxicillin in the cure of Helicobacter pylori infection in gastric ulcer patients. The Ulcer Study Group, Germany. Scandinavian Journal of Gastroenterology 1998;33(1):49-54.
40. Mones J, Rodrigo L, Sancho F, Martin L, Boixeda D, Artes MT, et al. Helicobacter pylori eradication versus one-year maintenance therapy: effect on relapse and gastritis outcome. Revista Espanola de Enfermedades Digestivas 2001;93(6):381-9.
41. O'Morain C, Dettmer A, Rambow A, von Fritsch E, Fraser AG. Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer. Helicobacter 1996;1(3):130-7.
42. Parente F, Maconi G, Bargiggia S, Colombo E, Bianchi PG. Comparison of two lansoprazole-antibiotic combinations (amoxycillin or classical triple therapy) for treatment of H. pylori infection in duodenal ulcer patients. Alimentary Pharmacology and Therapeutics 1996;10:211-3.
43. Pinero R, Pacheco M, Urrestarazu M, Serrano N, Olavarria R, Poleo JR. Helicobacter pylori eradication heals the duodenal ulcer. Randomized, simple, and controlled study with omeprazole. Revista de la Sociedad Venezolana de Gastroenterologia 1995;49(2):111-5.
44. Pounder RE, Wyeth JW, Duggan AE, Bailey RJ, Louw JA, Ohlin B, et al. Ranitidine bismuth citrate with clarithromycin for the eradication of Helicobacter pylori and for ulcer healing. Helicobacter 1997;2(3):132-9.
45. Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. The Lancet 1990;335:1233-5.
46. Schwartz H, Krause R, Sahba B, Haber M, Weissfeld A, Rose P, et al. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. American Journal of Gastroenterology 1998;93(4):584-90.
47. Shirotani T, Okada M, Murayama H, Maeda K, Seo M, Okabe N, et al. Effect of the eradication of Helicobacter pylori on duodenal ulcer healing and ulcer relapse: Randomized controlled study in Japan. Journal of Gastroenterology 1996;31(2):175-81.
48. Sobhani I, Chastang C, de Korwin JD, Lamouliatte H, Mégraud F, Guerre J, et al. Antibiotic versus maintenance therapy in the prevention of duodenal ulcer recurrence: Results of a multicentric double-blind randomized trial. Gastroenterologie Clinique et Biologique 1995;19(3):252-8.
49. Spinzi GC, Sangiovanni A, Imperiali G, Teruzzi V, Minoli G, Barabelli G, et al. Prevention of duodenal ulcer relapse with amoxycillin and omeprazole. European Journal of Gastroenterology and Hepatology 1994;6(11):599-602.
50. Suarez MS, Gonzalez CJ, Velasco IC, Sabatier CA, Castillo HJ. Three treatment schemes with colloidal bismuth subcitrate (Q-ULCER) in peptic ulcer with Helicobacter pylori. Archives of Medical Research 1999;30:55-9.
51. Sung JJ, Chung SC, Ling TK, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. New England Journal of Medicine 1995;332:139-42.
52. Tomita T, Fukuda Y, Tamura J, Tanaka J, Hida N, Kosaka T, et al. Successful eradication of Helicobacter pylori prevents relapse of peptic ulcer disease. Alimentary Pharmacology and Therapeutics 2002;16(Suppl 2):204-9.
53. Tulassay Z, Stolte M, Sjolund M, Engstrand L, Butruk E, Malfertheiner P, et al. Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients. European Journal of Gastroenterology and Hepatology 2008;20:526-36.
54. Unge P, Ekstrom P. Effects of combination therapy with omeprazole and an antibiotic on Helicobacter pylori and duodenal ulcer disease. Scandinavian Journal of Gastroenterology 1993;28 Suppl 196:17-8.
55. Unge P, Gad A, Eriksson K, Bergman B, Carline L, Ekstrom P, et al. Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients. European Journal of Gastroenterology and Hepatology 1993;5:325-31.
56. Van Zanten SJOV, Bradette M, Farley A, Leddin D, Lind T, Unge P, et al. The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Alimentary Pharmacology and Therapeutics 1999;13(3):289-95.
57. Wang WM, Chen CY, Jan CM, Chen LT, Perng DS, Lin SR, et al. Eradication of Helicobacter pylori infection and the recurrence of duodenal ulcers. Journal of the Formosan Medical Association 1993;92(8):721-4.
58. Wang K, Lin HJ, Chua RT, Perng CL, Tsay SH, Lee SD. Omeprazole plus amoxicillin versus triple therapy eradicates Helicobacter pylori in the Chinese with peptic ulcer disease. Chinese Medical Journal 1996;57(3):184-90.
59. Wong BC, Lam SK, Lai KC, Hu WH, Ching CK, Ho J, et al. Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study. Alimentary Pharmacology and Therapeutics 1999;13:303-9.
60. Al-Assi MT, Cole RA, Karttunen TJ, el-Zimaity H, Genta RM, Graham DY. Treatment of Helicobacter pylori infection with omeprazole-amoxicillin combination therapy versus ranitidine/sodium bicarbonate-amoxicillin. American Journal of Gastroenterology 1995;90(9):1411-4.
61. Bytzer P, Aalykke C, Rune S, Weywadt L, Gjørup T, Eriksen J, et al. Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group. Scandinavian Journal of Gastroenterology 2000;35(10):1023-32.
62. Dogan UB, Tuncer C, Dursun A, Kandilci U. A randomized prospective trial comparing results of different therapeutic regimens in the treatment of duodenal ulcer and Helicobacter pylori infection. Turkish Journal of Gastroenterology 1997;8:342-5.
63. Dumbleton JS, Avery A, Coupland C, Hobbs FDR, Kendrick D, Moore MV, et al. The Helicobacter Eradication Aspirin Trial (HEAT): A large simple randomised controlled trial using novel methodology in primary care. Gut 2015;64(Suppl 1):A294.
64. Dumbleton JS, Avery AJ, Coupland C, Hobbs FDR, Kendrick D, Moore MV, et al. The Helicobacter Eradication Aspirin Trial (HEAT): A large simple randomised controlled trial using novel methodology in primary care. EBioMedicine 2015;2(9):1200-4.
65. Gisbert JP, Blanco M, Pajares JM. Effect of Helicobacter pylori eradication on histological lesions of gastric mucosa. An 18-month follow-up study. Revista Clinica Espanola 2000;200(9):480-4.
66. Hosking SW, Ling TKW, Chung SCS, Yung MY, Cheng AF, Sung JJ, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. The Lancet 1994;343(8896):508-10.
67. Kohli Y, Kato T, Azuma T, Ito S, Hirai M. Lansoprazole treatment of Helicobacter pylori-positive peptic ulcers. Journal of Clinical Gastroenterology 1995;20 (Suppl 1):S48-S51.
68. Labenz J, Gyenes E, Rühl GH, Börsch G. Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. American Journal of Gastroenterology 1993;88(4):491-5.
69. Laine L, Fennerty MB, Osato M, Sugg J, Suchower L, Probst P, et al. Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials. American Journal of Gastroenterology 2000;95(12):3393-8.
70. Lind T, Veldhuyzen VZ, Unge P, Spiller R, Bayerdörffer E, O'Morain C, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter 1996;1(3):138-44.
71. Malfertheiner P, Dent J, Zeijlon L, Sipponen P, Veldhuyzen Van Zanten SJ, Burman CF, et al. Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease-results from a randomized trial programme. Alimentary Pharmacology and Therapeutics 2002;16(8):1431-42.
72. Nakata H, Itoh H, Nishioka S. Efficacy of lansoprazole and amoxicillin in eradicating Helicobacter pylori: evaluation using 13C-UBT and Monoclonal H. pylori antibody testing. Journal of Clinical Gastroenterology 1995;20 (Suppl 2):S118-S120.
73. O'Riordan T, Mathai E, Tobin E, McKenna D, Keane C, Sweeney E, et al. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. Gut 1990;31(9):999-1002.
74. Parente F, Bargiggia S, Bollani S, Colombo E, Bianchi Porro G. Continuous maintenance with low-dose lansoprazole versus Helicobacter pylori eradication in the prevention of duodenal ulcer recurrence. Hepato-Gastroenterology 1998;45:990-3.
75. Peterson WL, Ciociola AA, Sykes DL, McSorley DJ, Webb DD. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. Alimentary Pharmacology and Therapeutics 1996;10:251-61.
76. Prach AT, Malek M, Tavakoli M, Hopwood D, Senior BW, Murray FE. H2-antagonist maintenance therapy versus Helicobacter pylori eradication in patients with chronic duodenal ulcer disease: a prospective study. Alimentary Pharmacology and Therapeutics 1998;12:873-80.
77. Rune SJ, Justesen T, Hansen JM, Jensen TG, Eriksen J, Thomsen OO, et al. Prevention of duodenal ulcer recurrence with penicillin. Scandinavian Journal of Gastroenterology 1993;28(5):438-42.
78. Shimoyama T, Munakata A, Mizuki I, Akagi T, Fukuda S, Ohkawa K, et al. Eradication of Helicobacter pylori with lansoprazole and clarithromycin in gastric ulcer patients. Journal of Clinical Gastroenterology 1995;20 (Suppl 2):S125-7.
79. Sonnenberg A, Schwartz JS, Cutler AF, Vakil N, Bloom BS. Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial. Archives of Internal Medicine 1998;158:852-60.
80. Sonnenberg A, Pauly MP, Levenson SD, Schwartz JS. Antibiotic therapy of Helicobacter pylori infection reduces healthcare expenditures related to duodenal ulcer. American Journal of Managed Care 1999;5:53-9.
81. Sugiyama T, Hisano K, Ochiai T, Fujita N, Kobayashi T, Yabana T, et al. Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer. Journal of Clinical Gastroenterology 1995;20 (Suppl 2):S104-6.
82. Tavakoli M, Prach AT, Malek M, Hopwood D, Senior BW, Murray FE. Decision analysis of histamine H2-receptor antagonist maintenance therapy versus Helicobacter pylori eradication therapy: a randomised controlled trial in patients with continuing pain after duodenal ulcer. Pharmacoeconomics 1999;16(4):355-65.
83. Tham TC, Collins JS, Molloy C, Sloan JM, Bamford KB, Watson RG. Randomised controlled trial of ranitidine versus omeprazole in combination with antibiotics for eradication of Helicobacter pylori. Ulster Medical Journal 1996;65(2):131-6.
84. Veldhuyzen Van Zanten S, Farley A, Marcon N, Lahaie R, Archambault A, Hunt R, et al. Bismuth-based triple therapy with bismuth subcitrate, metronidazole and tetracycline in the eradication of Helicobacter pylori: A randomized, placebo controlled, double-blind study. Canadian Journal of Gastroneterology 2000;14(7):599-602.
85. Xia HX, Gilvarry J, Beattie S, Hamilton H, Keane CT, Sweeney EC, et al. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens. American Journal of Gastroenterology 1995;90(8):1221-5.
86. Barkun A, Leontiadis G. Systematic review of the symptom burden, quality of life impairment and costs associated with peptic ulcer disease. The American Journal of Medicine 2010;123(4):358-66.e2.
87. Begg CB, Mazumdar M. Operating Characteristics of a Rank Correlation Test for Publication Bias. Biometrics 1994;50(4):1101-088.
88. Briggs AH, Sculpher MJ, Logan RP, Aldous J, Ramsay ME, Baron JH, et al. Cost-effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age. BMJ 1996;312(7042):1321-5.
89. Dobrilla G, Zancanella L, Amplatz S. The need for long-term treatment of peptic ulcer. Alimentary Pharmacology and Therapeutics. 1993;7 (Suppl 2):3-15.
90. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
91. Feldman M. Suppression of acid secretion in peptic ulcer disease. Journal of Clinical Gastroenterology 1995;20 (Suppl 1):s1-6.
92. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-560.
93. Higgins JPT, Altman DG, Sterne JAC, Cochrane Statistical Methods Group, Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. In Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
94. Howden C, Hunt RH. Guidelines for the management of Helicobacter pylori. American Journal of Gastroenterology 1998;93:2330-8.
95. Hunt RH. Peptic ulcer disease: defining the treatment strategies in the era of Helicobacter pylori. American Journal of Gastroenterology 1997;92(Suppl 4):36s-40s.
96. Imperiale TF, Speroff T, Cebul RD, McCullough AJ. A cost analysis of alternative treatments for duodenal ulcer. Annals of Internal Medicine 1995;123(9):665-72.
97. Lau J, Ioannidis JPA, Schmidt CH. Summing up evidence: one answer is not always enough. Lancet 1998;351:123-7.
98. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
99. Leodolter A, Kulig M, Brasch H, Meyer-Sabellek W, Willich SN, Malfertheiner P. A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer. Alimentary Pharmacology and Therapeutics 2001;15(12):1949-58.
100. Malfertheiner P, Mégraud F, O'Morain C, Hungin AP, Jones R, Axon A, et al. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. Alimentary Pharmacology and Therapeutics 2002;16(2):167-80.
101. Moayyedi P, Feltbower R, Crocombe W, Mason S, Atha P, Brown J, et al. The effectiveness of omeprazole, clarithromycin and tinidazole in eradicating Helicobacter pylori in a community screen and treat programme. Alimentary Pharmacology and Therapeutics 2000;14(6):719-28.
102. Moher D, Cook DJ, Jadad AR, Tugwell P, Moher M, Jones A. Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses. Health Technology Assessment 1999;3(12):i-iv.
103. Moore RA. Helicobacter pylori and peptic ulcer. A systematic review of effectiveness and an overview of the economic benefits of implementing what is known to be effective. http://www.jr2.ox.ac.uk/bandolier 1994.
104. Penston JG. A decade of experience with long-term continuous treatment of peptic ulcers with H2-receptor antagonists. Alimentary Pharmacology and Therapeutics. 1993;7 (Suppl 2):27-33.
105. Penston JG. Clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease. Alimentary Pharmacology and Therapeutics 1996;10(4):469-86.
106. Peterson WL. Pathogenesis and therapy of peptic ulcer disease. Journal of Clinical Gastroenterology 1990;12 (Suppl 2):s1-6.
107. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
108. Tytgat GN. Treatment of peptic ulcer. Digestion 1998;59(5):446-52.
109. Ford A, Delaney B, Moayyedi P. A systematic review of Helicobacter pylori eradication therapy in duodenal and gastric ulcer healing and maintenance. Gut. 2003; Vol. 52 (suppl I):A17.
110. Ford AC, Delaney B, Forman D, Moayyedi P. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive patients. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD003840.pub4]